Innospec Inc. Announces Expansion of Stock Repurchase Program and Dividend Increase

Innospec Inc. (NYSE: IOP) today announced that its Board of Directors has authorized the acceleration of the Company's stock repurchase program with the intention of spending up to $15 million over the next twelve months.

The timing of purchases and the exact number of stock to be purchased will depend on market conditions. The buyback program does not include specific price targets or timetables and may be suspended at any time.

The Company intends to immediately enter into a Rule 10b5-1 plan to facilitate repurchases of its stock under this program as well as maintaining its strategy of making additional repurchases in the open market outside of the Rule 10b5-1 plan. The plan will allow the Company to repurchase up to 300,000 shares of common stock. The plan will run until April 26, 2006.

Innospec also announced that its Board of Directors has declared a final dividend for full year 2005 of $0.08 (eight cents), an increase of 14% per share from the 2004 final dividend. The dividend is payable on April 1, 2006 to the holders of record of the common stock of the corporation on February 17, 2006.

Paul Jennings, President and Chief Executive Officer of Innospec Inc. said, "Expanding our buyback program and increasing our dividend by 14% is an excellent use of Innospec's capital that reflects the Company's strong cash generation, as well as our confidence in the Company's growth strategy and commitment to enhancing shareholder value."

<!-- BEGIN: AdSolution-Website-Tag 4.1 : RedNova / RedNova_News_Stories_300x250_Top_Left -->< script language=JavaScript type=text/javascript>Ads_kid=0;Ads_bid=0;Ads_xl=300;Ads_yl=250;Ads_xp='';Ads_yp='';Ads_opt=0;Ads_wrd=Ads_RVS;Ads_prf='';Ads_par='';Ads_cnturl='';Ads_sec=0;Ads_channels='';< /script>< script language=javascript src="http://a.as-us.falkag.net/dat/cjf/00/02/59/11.js" type=text/javascript>< /script>< script language=JavaScript src="http://data.as-us.falkag.net/server/asldata.js" type=text/javascript>< /script>< script language=JavaScript src="http://a.as-us.falkag.net/dat/bjf/00/06/66/45.js" type=text/javascript>< /script>< script language=JavaScript>function Ads_PopUp() {}< /script>< script language=JavaScript src="http://a.as-us.falkag.net/dat/brf/00/21/13/36.js" type=text/javascript>< /script>< script language=JavaScript src="http://anad.tacoda.net/cgi-bin/ads/ad11620a.cgi/v=2.0S/sz=300x250a/58653/RETURN-CODE/JS/">< /script>< iframe marginWidth=0 marginHeight=0 src="http://www.rednova.com/_include/banners/ads4.html" frameBorder=0 width=300 scrolling=no height=250>< /iframe><!-- END:AdSolution-Tag 4.1 -->

About Innospec Inc.

Innospec Inc. is an international specialty chemical company with almost 1,000 employees in 21 countries. Innospec divides its operations into three distinct business areas: Fuel Specialties, Performance Chemicals, and Octane Additives. Together, the three businesses manufacture and supply a wide range of specialty chemicals to markets in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Innospec's Fuel Specialties business specialises in manufacturing and supplying the fuel additives that help improve fuel efficiency, boost engine performance and reduce harmful emissions. Innospec's Performance Chemicals business includes a range of companies that manufacture performance chemicals used in the manufacture of such items as personal care products, household detergents, crop protection chemicals as well as in the plastics, paper and fungicides and in the metal plating and oil industries. Innospec's Octane Additives business is the world's only producer of tetra ethyl lead (TEL). The management team has a clear strategy in place to ensure the Company maximizes shareholder value from TEL supply while monitoring and reducing production in line with global demand.

FORWARD-LOOKING STATEMENTS

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements which address operating performance, events or developments that we expect or anticipate will occur in the future. Although such statements are believed by management to be reasonable when made, caution should be exercised not to place undue reliance on forward-looking statements, which are subject to certain risks, uncertainties and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, actual results may differ materially from those expressed or implied by such forward-looking statements and assumptions. Risks, assumptions and uncertainties include, without limitation, changes in the terms of trading with significant customers or gain or loss thereof, the effects of changing government regulations and economic and market conditions, competition and changes in demand and business and legal risks inherent in non-U.S. activities, including political and economic uncertainty, import and export limitations and market risks related to changes in interest rates and foreign exchange rates, government investigations, material fines or other penalties resulting from the Company's voluntary disclosure to the Office of Foreign Assets Control of the U.S. Department of the Treasury and other risks, uncertainties and assumptions identified in the Company's Annual Report on Form 10-K for the year ended December 31, 2004 and those identified in the Company's other reports filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Source: Business Wire

 

NEWARK, Del., Feb 24, 2006 (BUSINESS WIRE) -- Innospec Inc. (NYSE: IOP) today announced that one of its subsidiaries in the UK, The Associated Octel Company Limited, has achieved a notable victory in its long-running invalidity action against an important patent owned by Infineum USA LP.

In a final decision, the Technical Board of Appeal of the European Patent Office (EPO) agreed with Innospec and three other opponents that the patent (EP 0743974) was not inventive, and ordered it to be revoked. The decision revokes not only the United Kingdom Patent, but the equivalent patent in all European countries where it was in force through grant by the EPO.

Infineum's patent, which covered the use in low sulphur diesel fuel of a combination of ester-based lubricity enhancers with EVA cold flow improvers, was granted in 2000, and had been the subject of proceedings to revoke it for more than 5 years.

This latest success completes a series of similar actions that have been concluded in the past year, the overall result of which has been to open up the field of diesel additives, and give customers much less restricted choice. Innospec and the same three other opponents as noted above also opposed European Patent EP 0743972 owned by Infineum covering the use in diesel fuel of a combination of polar nitrogen compounds and ester lubricity enhancers, arguing, as last week, that it was not inventive: the Board of Appeal agreed, and revoked the patent. Similarly, Infineum's EP 0764198, covering a combination of polar nitrogen compounds and EVA was also revoked for lack of inventive step. The major part of yet another patent owned by Infineum, EP 0807155, which was for diesel fuel containing succinimide detergents and ester lubricity enhancers, was also revoked by the EPO last November following proceedings brought by two opponents, including Innospec.

Patent attorneys Appleyard Lees worked with a team of specialist patent litigators from Addleshaw Goddard to help Innospec achieve its latest success.

A spokesperson for Innospec stated, "As an innovator and owner of substantial intellectual property, we respect patents owned by others. However, we remain fully committed to taking action to defend the right of customers to choose to purchase Innospec's products when we believe they are unfairly prevented from doing so. Customers will now be free to use Innospec's lubricity additives free from the risk of being sued for infringement of these invalid patents."

About Innospec Inc.

Innospec Inc. is an international specialty chemical company with almost 1,000 employees in 23 countries. Innospec divides its operations into three distinct business areas: Fuel Specialties, Performance Chemicals, and Octane Additives. Together, the three businesses manufacture and supply a wide range of specialty chemicals to markets in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Innospec's Fuel Specialties business specialises in manufacturing and supplying the fuel additives that help improve fuel efficiency, boost engine performance and reduce harmful emissions. Innospec's Performance Chemicals business includes a range of companies that manufacture performance chemicals used in the manufacture of such items as personal care products, household detergents, crop protection chemicals as well as in the plastics, paper and fungicides and in the metal plating and oil industries. Innospec's Octane Additives business is the world's only producer of tetra ethyl lead (TEL). The management team has a clear strategy in place to ensure the Company maximizes shareholder value from TEL supply while monitoring and reducing production in line with global demand.

SOURCE: Innospec Inc.

CONTACT: Innospec Inc. Investor Relations Andrew Hartley, +44-151-348-5846 or Citigate Sard Verbinnen Victoria Hofstad, 212-687-8080

Copyright Business Wire 2006

KEYWORD: United States

North America

Delaware

INDUSTRY KEYWORD: Manufacturing

Chemicals/Plastics

 

Enter Symbol or Keyword:	Time Frame:
	1-day2 days5 days10 days----------1 month2 months3 months6 monthsYTD1 year2 years3 years4 years5 years1 decadeAll Data		Additional chart controls

IOP - Innospec Inc (NYSE)

2:42 PM ET, 3/14/2006

 

NASDAQ: Innospec switches its stock listing to NASDAQ Trading under new symbol 'IOSP' to commence on March 22, 2006

New York, Mar 16, 2006 (M2 PRESSWIRE via COMTEX) -- Innospec Inc. (NYSE: IOP) (NASDAQ: IOSP) announced today that it will list its common stock solely on the NASDAQ Stock Market and discontinue the company's listing with the New York Stock Exchange. The international specialty chemicals company's common stock will cease trading under the symbol IOP on theNYSE on March 21, 2006. Innospec's stock will begin trading on NASDAQ under the new symbol IOSP when the market opens on March 22, 2006. Paul Jennings, President and Chief Executive Officer of Innospec, stated, "After careful analysis, we believe a NASDAQ listing switch will provide increased visibility for our shares and a more cost-effective trading solution. Our move to NASDAQ goes hand-in-hand with Innospec's new strategic direction as the leading provider of specialty chemical solutions in our chosen markets." Bruce Aust, Executive Vice President, NASDAQ's corporate client group, said, "We are delighted to welcome Innospec as the first chemicals company to switch to a NASDAQ listing. Innospec joins many of the world's most innovative companies in recognizing that NASDAQ's more transparent, faster, electronic market is an ideal setting for a company that is seeking to broaden awareness about its new direction, core business focus and improved capital management." Innospec Inc. is an international specialty chemicals company with almost 1,000 employees in 23 countries. Innospec divides its operations into three distinct business areas: Fuel Specialties, Performance Chemicals, and Octane Additives. Together, the three businesses manufacture and supply a wide range of specialty chemicals to markets in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Innospec's Fuel Specialties business specializes in manufacturing and supplying the fuel additives that help improve fuel efficiency, boost engine performance and reduce harmful emissions. Innospec's Performance Chemicals business includes a range of companies that manufacture performance chemicals used in the manufacture of such items as personal care products, household detergents, crop protection chemicals as well as in the plastics, paper, metal plating and oil industries. Innospec's Octane Additives business is the world's only producer of tetra ethyl lead (TEL). NASDAQ is the largest electronic screen-based equity securities market in the United States. With approximately 3,200 companies, it lists more companies and, on average, trades more shares per day than any other U.S. market. It is home to companies that are leaders across all areas of business including technology, retail, communications, financial services, transportation, media and biotechnology. NASDAQ is the primary market for trading NASDAQ-listed stocks. For more information about NASDAQ, visit the NASDAQ Web site at www.nasdaq.com or the NASDAQ Newsroom at www.nasdaq.com/newsroom/. Forward-Looking Statements This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward- looking statements include all statements which address operating performance, events or developments that we expect or anticipate will occur in the future. Although such statements are believed by management to be reasonable when made, caution should be exercised not to place undue reliance on forward- looking statements, which are subject to certain risks, uncertainties and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, actual results may differ materially from those expressed or implied by such forward-looking statements and assumptions.Risks, assumptions and uncertainties include, without limitation,changes in the terms of trading with significant customers or gain or loss thereof, the effects of changing government regulations and economic and market conditions, competition and changes in demand and business and legal risks inherent in non-U.S. activities, including political and economic uncertainty, import and export limitations and market risks related to changes in interest rates and foreign exchange rates, government investigations, material fines or other penalties resulting from the Company's voluntary disclosure to the Office of Foreign Assets Control of the U.S. Department of the Treasury and other risks, uncertainties and assumptions identified in the Company's Annual Report on Form 10-K for the year ended December 31, 2004 and those identified in the Company's other reports filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward- looking statements, whether as a result of new information, future events or otherwise. M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web Inquiries to info@m2.com. (C)1994-2006 M2 COMMUNICATIONS LTD

 

Mein Einstieg bei 19.90 $

INNOSPEC INC - Nasdaq National Market: IOSP (NEW charting help)

Time Frame:   1-day2 days5 days10 days----------1 month2 months3 months6 monthsYTD1 year2 years3 years4 years5 years1 decadeAll Data Additional chart controls  IOSP - Innospec Inc (NASDAQ NM) 4:00 PM ET, 3/31/2006

 

 Innospec Inc. First Quarter 2006 Results Conference Call
NEWARK, Del., Apr 03, 2006 (BUSINESS WIRE) -- Innospec Inc. (NASDAQ: IOSP), an international chemical company specializing in the manufacture, distribution and marketing of fuel additives and specialty chemicals, announced that the company will report first quarter 2006 results on Monday, April 24, 2006, after the close of the market. Following the release of its results, the company will host a conference call for the investment community on Tuesday, April 25, 2006. Hosting the call will be Paul Jennings, President and Chief Executive Officer, and Jim Lawler, Executive Vice President and Chief Financial Officer of Innospec Inc.

The call will begin promptly at 8:30 A.M. EDT and can be accessed using the dial-in numbers 1 (866) 322-0547 (toll free) or 1 (706) 758-0596 (international) or via a simultaneous webcast on the company website www.innospecinc.com. The webcast and audio replay will be available beginning at 11:30 A.M. EDT on April 25 until 11:30 P.M. EDT on May 9, 2006. The replay numbers are 1 (800) 642-1687 (toll free) and 1 (706) 645-9291 (international), conference ID # 7470835.

About Innospec Inc.

Innospec Inc., a Delaware corporation, is an international specialty chemical company focused on providing unique and value added solutions in the fuel additives and performance chemicals markets. The Company's operations divide into three distinct businesses - Fuel Specialties, Performance Chemicals and Octane Additives. Innospec employs almost 1,000 people in 21 countries with manufacturing bases in many countries and a worldwide distribution network already in place. The business had annual revenues in excess of $527 million in fiscal year 2005.

SOURCE: Innospec Inc.

CONTACT: Innospec Inc. Investor Relations Andrew Hartley, +011-44-151 348 5846 or Citigate Sard Verbinnen Victoria Hofstad, +1 212-687-8080

Copyright Business Wire 2006

KEYWORD: United States

North America

Delaware

INDUSTRY KEYWORD: Energy

Oil/Gas

Other Energy

Manufacturing

Chemicals/Plastics

Other Manufacturing

Professional Services

Finance

SUBJECT CODE: Earnings

Conference Call

Webcast

 

Innospec Announces Further Stock Repurchase PlanE-mail | Print | | Disable live quotes Last Update: 4:45 PM ET May 2, 2006
NEWARK, Dela., May 02, 2006 (BUSINESS WIRE) -- Innospec Inc. (IOSP : innospec inc comNews , chart, profile, moreLast: 25.77+0.99+4.00%
6:06pm 05/03/2006
Delayed quote data Add to portfolio
Analyst
Create alertInsider
Discuss
Financials Sponsored by:
IOSP25.77, +0.99, +4.0%) today announced that its Board of Directors has authorized a further Rule 10b5-1 stock re-purchase plan. The plan will commence on May 8, 2006, and complete on July 26, 2006. Under the new plan, the Company may re-purchase up to 420,000 shares of common stock. The Company successfully completed a similar plan earlier this year. Paul Jennings, Innospec's President and CEO commented: "The decision to initiate a second 10b5-1 plan this year underlines Innospec's drive to increase shareholder value. The new plan will be funded from cash generated from the divestment of non-core activities and demonstrates a responsible approach to capital management." About Innospec Inc. Innospec Inc. is an international specialty chemical company with almost 1,000 employees in 23 countries. Innospec divides its operations into three distinct business areas: Fuel Specialties, Performance Chemicals, and Octane Additives. Together, the three businesses manufacture and supply a wide range of specialty chemicals to markets in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Innospec's Fuel Specialties business specialises in manufacturing and supplying the fuel additives that help improve fuel efficiency, boost engine performance and reduce harmful emissions. Innospec's Performance Chemicals business includes a range of companies that manufacture performance chemicals used in the manufacture of such items as personal care products, household detergents, crop protection chemicals as well as in the plastics, paper and fungicides and in the metal plating and oil industries. Innospec's Octane Additives business is the world's only producer of tetra ethyl lead (TEL). The management team has a clear strategy in place to ensure the Company maximizes shareholder value from TEL supply while monitoring and reducing production in line with global demand. Forward-Looking Statements his press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements which address operating performance, events or developments that we expect or anticipate will occur in the future. Although such statements are believed by management to be reasonable when made, caution should be exercised not to place undue reliance on forward-looking statements, which are subject to certain risks, uncertainties and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, actual results may differ materially from those expressed or implied by such forward-looking statements and assumptions. Risks, assumptions and uncertainties include, without limitation, changes in the terms of trading with significant customers or gain or loss thereof, the effects of changing government regulations and economic and market conditions, competition and changes in demand and business and legal risks inherent in non-U.S. activities, including political and economic uncertainty, import and export limitations and market risks related to changes in interest rates and foreign exchange rates, government investigations, material fines or other penalties resulting from the Company's voluntary disclosure to the Office of Foreign Assets Control of the U.S. Department of the Treasury and other risks, uncertainties and assumptions identified in the Company's Annual Report on Form 10-K for the year ended December 31, 2005 and those identified in the Company's other reports filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. SOURCE: Innospec Inc. Innospec Inc. Investor RelationsAndrew Hartley, +44-151-348-5846  orCitigate Sard VerbinnenVictoria Hofstad, 212/687-8080Copyright Business Wire 2006  

INNOSPEC INC - Nasdaq National Market: IOSP (NEW charting help)

<!--VITALS="app:interactivecharting lic:destination sale:kek web:kjb ops:ccn tech:cdt"-->

Enter Symbol or Keyword: Time Frame:   1-day2 days5 days10 days----------1 month2 months3 months6 monthsYTD1 year2 years3 years4 years5 years1 decadeAll Data Additional chart controls  IOSP - Innospec Inc (NASDAQ NM) 5/9/2006

Dividende auch schon mitgenommen.  

P

2006-05-04- -2006-05-05

2006-05-08 18:45:54

INNOSPEC INC.

IOSP

GENDELL JEFFREY L ET AL

10% owner

39,900

$25.87

$1,032,297

2,151,700

Indirect

View

P

2006-05-02

2006-05-02 11:55:50

INNOSPEC INC.

IOSP

Williams Patrick

Exec VP & President, Pet Specs

300

$23.98

$7,193

2,600

Direct

View

P

2006-02-24

2006-02-27 12:38:08

INNOSPEC INC.

IOP

Dawson William Martin

Exec VP Performance Chemicals

1,017

$21.98

$22,351

1,629

Direct

View

P

2006-02-24

2006-02-27 07:58:05

INNOSPEC INC.

IOP

HESSNER CATHERINE

Senior VP Human Resources

350

$21.98

$7,692

656

Direct

View

P

2006-02-24

2006-02-27 07:57:02

INNOSPEC INC.

IOP

MCROBBIE IAN MALCOLM

Chief Technolgy Officer

815

$21.98

$17,912

1,133

Direct

View

P

2006-02-24

2006-02-27 07:56:26

INNOSPEC INC.

IOP

JENNINGS PAUL WILLIS

Director

2,663

$21.98

$58,526

5,333

Direct

View

P

2006-02-22- -2006-02-23

2006-02-24 16:35:26

INNOSPEC INC.

IOP

TONTINE CAPITAL PARTNERS L P

10% owner

81,400

$21.96

$1,787,544

2,111,800

Direct

 

Chartsignal aktuell Buy!!  

INNOSPEC INC. DL-,01

Übersicht     Kurse     Charts     News     Forum

WKN: A0H1E7   ISIN: US45768S1050   Einfügen in: Watchlist | Depot

<!--  #overDiv <!--  Intraday  5 Tage  3 Monate  1 Jahr  3 Jahre  Gesamt  Frei    HTML-Code dieses Charts für

__________________________________________________
"Malo mori quam foederari - Lieber sterben als sich entehren"  

Neue Einstiegsschance, nur in deutschland fast kein Umsatz.

_INNOSPEC INC - Nasdaq National Market: IOSP
Real-time ECN Quote*

Last	Change (%)	Trade Time	Bid	Ask
23.42	4.7 (25.11)	13:07	21 (10)	24 (1)

Looking for unlimited real-time exchange quotes?  FRT Express special offer

---

Exchange Quote

Last	Change (%)	Trade Time	Bid (size)	Ask (size)
23.36	4.64 (24.79)	12:50	23.27 (2)	23.34 (5)
Latest Ticks	Prev Close	Open	Low	High
+-+-	18.72	18.80	18.46	23.83
Day Volume	Avg Day Vol	VWAP	52 Wk Low	52 Wk High
299,560	226,200	21.4847	11.20	32.45
# of Trades	Last Size	Avg Trade Size	P/E Ratio	Market Cap (mil)
1,458	100	205	26	563

1:10:43 PM EDT - Friday, August 10, 2007
__________________________________________________ "Malo mori quam foederari - Lieber sterben als sich entehren"

 

 

https://de.marketscreener.com/kurs/aktie/INNOSPEC-INC-16318/

https://innospec.com/
https://innospec.com/wp-content/uploads/2024/02/...3_Presentation.pdf

https://www.finanzen.net/schaetzungen/innospec

https://www.gurufocus.com/stock/IOSP/summary